The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Triclosan and Antimicrobial Resistance in Bacteria: An Overview
Abstract
Triclosan is a widely used biocide that is considered as an effective antimicrobial agent against different microorganisms. It is included in many contemporary consumer and personal health-care products, like oral and dermal products, but also in household items, including plastics and textiles. At bactericidal concentrations, triclosan appears to act upon multiple nonspecific targets, causing disruption of bacterial cell wall functions, while at sublethal concentrations, triclosan affects specific targets. During the 1990s, bacterial isolates with reduced susceptibility to triclosan were produced in laboratory experiments by repeated exposure to sublethal concentrations of the agent. Since 2000, a number of studies have verified the occurrence of triclosan resistance amongst dermal, intestinal, and environmental microorganisms, including some of clinical relevance. Of major concern is the possibility that triclosan resistance may contribute to reduced susceptibility to clinically important antimicrobials, due to either cross-resistance or co-resistance mechanisms. Although the number of studies elucidating the association between triclosan resistance and resistance to other antimicrobials in clinical isolates has been limited, recent laboratory studies have confirmed the potential for such a link in Escherichia coli and Salmonella enterica. Thus, widespread use of triclosan may represent a potential public health risk in regard to development of concomitant resistance to clinically important antimicrobials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Pharmaceuticals and personal care products in the environment: agents of subtle change?
Daughton, C. G., & Ternes, T. A. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107s6907 · Cited by 4,705
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Inactivation of Antibiotics and the Dissemination of Resistance Genes
Davies, J. (1994) · Science · doi:10.1126/science.8153624 · Cited by 1,730
Triclosan targets lipid synthesis
McMurry, L. M., Oethinger, M., & Levy, S. B. (1998) · Nature · doi:10.1038/28970 · Cited by 1,019
Dental Caries: The Disease and its Clinical Management
Fejerskov, O., & Kidd, E. (2015) · Cited by 846
Urinary Concentrations of Triclosan in the U.S. Population: 2003–2004
Calafat, A. M., Ye, X., Wong, L.-Y., Reidy, J. A., & Needham, L. L. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10768 · Cited by 553
The impact of antibiotic use on resistance development and persistence
Barbosa, T. M., & Levy, S. B. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0167 · Cited by 493
Triclosan: A review of effectiveness and safety in health care settings
Jones, R. D., Jampani, H. B., Newman, J. L., & Lee, A. S. (2000) · American Journal of Infection Control · doi:10.1016/s0196-6553(00)90027-0 · Cited by 487
Oral hygiene in the prevention of caries and periodontal disease
Löe, H. (2000) · International Dental Journal · doi:10.1111/j.1875-595x.2000.tb00553.x · Cited by 453
Measurement of triclosan in wastewater treatment systems
McAvoy, D. C., Schatowitz, B., Jacob, M., Hauk, A., & Eckhoff, W. S. (2002) · Environmental Toxicology and Chemistry · doi:10.1002/etc.5620210701 · Cited by 448
Chuanchuen, R., Beinlich, K., Hoang, T. T., Becher, A., Karkhoff-Schweizer, R. R., & Schweizer, H. P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.428-432.2001 · Cited by 426
Mcmurry, L. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00347-4 · Cited by 354
Harbarth, S., Dharan, S., Liassine, N., Herrault, P., Auckenthaler, R., & Pittet, D. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1412 · Cited by 286
A triclosan-resistant bacterial enzyme
Heath, R. J., & Rock, C. O. (2000) · Nature · doi:10.1038/35018162 · Cited by 284
Braoudaki, M., & Hilton, A. C. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.73-78.2004 · Cited by 273
Triclosan and antibiotic resistance in Staphylococcus aureus
Suller, M. T. E. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.1.11 · Cited by 261
Effectiveness of some recent antimicrobial packaging concepts
Vermeiren, L., Devlieghere, F., & Debevere, J. (2002) · Food Additives & Contaminants · doi:10.1080/02652030110104852 · Cited by 242
Heath, R. J., Li, J., Roland, G. E., & Rock, C. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4654 · Cited by 240
Inhibition of InhA, the Enoyl Reductase from Mycobacterium tuberculosis, by Triclosan and Isoniazid
Parikh, S. L., Xiao, G., & Tonge, P. J. (2000) · Biochemistry · doi:10.1021/bi0008940 · Cited by 238
Antibacterial Household Products: Cause for Concern
Levy, S. B. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0707.017705 · Cited by 230
Genetic Evidence that InhA of Mycobacterium smegmatis Is a Target for Triclosan
McMurry, L. M., McDermott, P. F., & Levy, S. B. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.711 · Cited by 214
Hoang, T. T., & Schweizer, H. P. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.17.5489-5497.1999 · Cited by 212
Antibiotic resistance in general dental practice--a cause for concern?
Sweeney, L. C. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh137 · Cited by 211
Vartivarian, S., Anaissie, E., Bodey, G., Sprigg, H., & Rolston, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.3.624 · Cited by 199
Zafar, A. B., Butler, R. C., Reese, D. J., Gaydos, L. A., & Mennonna, P. A. (1995) · American Journal of Infection Control · doi:10.1016/0196-6553(95)90042-x · Cited by 161
Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis
Goss, C. H., Mayer-Hamblett, N., Aitken, M. L., Rubenfeld, G. D., & Ramsey, B. W. (2004) · Thorax · doi:10.1136/thx.2003.017707 · Cited by 159
Xanthomonas maltophilia: An Emerging Nosocomial Pathogen
MARSHALL, W. F., Keating, M. R., Anhalt, J. P., & Steckelberg, J. M. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)64979-9 · Cited by 139
Antiplaque biocides and bacterial resistance: a review
Sreenivasan, P. K., & Gaffar, A. (2002) · Journal Of Clinical Periodontology · doi:10.1034/j.1600-051x.2002.291101.x · Cited by 137
Piddock, L. J. V., White, D. G., Gensberg, K., Pumbwe, L., & Griggs, D. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3118-3121.2000 · Cited by 137
Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli
Maneewannakul, K., & Levy, S. B. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.7.1695 · Cited by 135
Antibiotic and antiseptic resistance: impact on public health
Levy, S. B. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200010001-00008 · Cited by 134
Meade, M. J., Waddell, R. L., & Callahan, T. M. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10860.x · Cited by 131
Webster, J., FAOAGALI, J. L., & CARTWRIGHT, D. (1994) · Journal of Paediatrics and Child Health · doi:10.1111/j.1440-1754.1994.tb00568.x · Cited by 126
Sanchez, P., Moreno, E., & Martínez, J. L. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.781-782.2005 · Cited by 122
Effect of triclosan on Salmonella typhimurium at different growth stages and in biofilms.
Tabak, M., Scher, K., Hartog, E., Romling, U., Matthews, K., Chikindas, M., & Yaron, S. (2007) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2006.00547.x · Cited by 121
Davies, R. M., Ellwood, R. P., & Davies, G. (2004) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2004.00614.x · Cited by 113
Erratum: A triclosan-resistant bacterial enzyme
Heath, R. J., & Rock, C. O. (2000) · Nature · doi:10.1038/35022656 · Cited by 112
Wara‐aswapati, N., Krongnawakul, D., Jiraviboon, D., Adulyanon, S., Karimbux, N. Y., & Pitiphat, W. (2005) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2004.00631.x · Cited by 111
A field study of triclosan loss rates in river water (Cibolo Creek, TX)
Morrall, D. D., McAvoy, D. C., Schatowitz, B., Inauen, J., Jacob, M., Hauk, A., & Eckhoff, W. S. (2003) · Chemosphere · doi:10.1016/j.chemosphere.2003.08.002 · Cited by 109
Reichmann, P., König, A. A., Liñares, J., Alcaide, F., Tenover, F. C., McDougal, L. K., Swidsinski, S., & Hakenbeck, R. (1997) · The Journal of Infectious Diseases · doi:10.1086/516532 · Cited by 99
Bamber, A. I., & Neal, T. J. (1999) · Journal of Hospital Infection · doi:10.1016/s0195-6701(99)90047-6 · Cited by 98
Fan, F., Yan, K., Wallis, N. G., Reed, S. L., Moore, T. D., Rittenhouse, S. F., DeWolf, W. E., Huang, J., McDevitt, D., Miller, W. H., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3343-3347.2002 · Cited by 97
Braoudaki, M. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.04.049 · Cited by 97
Randall, L. P., Cooles, S. W., Piddock, L. J. V., & Woodward, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh376 · Cited by 89
Braoudaki, M., & Hilton, A. C. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09603.x · Cited by 89
Resistance to antibiotics used in dermatological practice
Espersen (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.1390s3004.x · Cited by 87
Relationship between Triclosan and Susceptibilities of Bacteria Isolated from Hands in the Community
Aiello, A. E., Marshall, B. M., Levy, S. B., Della‐Latta, P., & Larson, E. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.2973-2979.2004 · Cited by 85
Johnson, S. A., Goddard, P., Iliffe, C., et al. (2002) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2002.01691.x · Cited by 84
The Effectiveness of Triclosan-Incorporated Plastic against Bacteria on Beef Surfaces
Cutter, C. N. (1999) · Journal of Food Protection · doi:10.4315/0362-028x-62.5.474 · Cited by 83
Selection for high-level resistance by chronic triclosan exposure is not universal
McBain, A. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh168 · Cited by 82
In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas
Bébéar, C. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.5.711 · Cited by 82
Randall, L. P. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg379 · Cited by 79
Transferable resistance to triclosan in MRSA
Cookson, B., Farrelly, H. D., Stapleton, P. D., Garvey, R., & Price, M. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)93242-2 · Cited by 78
Residues of 4-chloro-1-(2,4-dichlorophenoxy)-2-methoxybenzene(triclosan methyl) in aquatic biota
Miyazaki, T., Yamagishi, T., & Matsumoto, M. (1984) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/bf01607490 · Cited by 73
Volpe, A. R., Petrone, M. E., DeVizio, W., Davies, R. M., & Proskin, H. M. (1993) · PubMed · Cited by 65
Cullinan, M. P., Hamlet, S. M., Westerman, B., Palmer, J. E., Faddy, M. J., & Seymour, G. J. (2003) · Journal of Clinical Periodontology · doi:10.1034/j.1600-051x.2003.00292.x · Cited by 61
Cullinan, M. P., Westerman, B., Hamlet, S. M., Palmer, J. E., Faddy, M. J., & Seymour, G. J. (2003) · Journal Of Clinical Periodontology · doi:10.1034/j.1600-051x.2003.20030.x · Cited by 61
McBain, A. J., Bartolo, R. G., Catrenich, C. E., Charbonneau, D. L., Ledder, R. G., & Gilbert, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3531-3538.2003 · Cited by 58
White, D. G., Maneewannakul, K., Hofe, E. V., Zillman, M. A., Eisenberg, W., Field, A., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2699 · Cited by 47
Molecular Evolution of Multiply‐Antibiotic‐Resistant Staphylococci
Skurray, R. A., & Firth, N. (2007) · Novartis Foundation symposium · doi:10.1002/9780470515358.ch11 · Cited by 41
Walker, C., Borden, L., Zambon, J. J., Bonta, C. Y., DeVizio, W., & Volpe, A. R. (1994) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.1994.tb00722.x · Cited by 36
Reduced Triclosan Susceptibility in Methicillin-Resistant Staphylococcus epidermidis
Schmid, M. B., & Kaplan, N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1397-1399.2004 · Cited by 27
Antimicrobial Consumer Products
Levy, S. B. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.8.1087 · Cited by 9
Cited by
Efflux-mediated antimicrobial resistance
Poole, K. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki171 · Cited by 1,082
Triclosan: environmental exposure, toxicity and mechanisms of action
Dann, A. B., & Hontela, A. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1660 · Cited by 868
Urinary Concentrations of Triclosan in the U.S. Population: 2003–2004
Calafat, A. M., Ye, X., Wong, L.-Y., Reidy, J. A., & Needham, L. L. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10768 · Cited by 553
Restuccia, D., Spizzirri, U. G., Parisi, O. I., Cirillo, G., Curcio, M., Iemma, F., Puoci, F., Vinci, G., & Picci, N. (2010) · Food Control · doi:10.1016/j.foodcont.2010.04.028 · Cited by 512
Barra Caracciolo, A., Topp, E., & Grenni, P. (2015) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2014.11.040 · Cited by 453
Metadata
- Authors
- Yazdankhah, S. P., Scheie, A. A., H⊘iby, E. A., Lunestad, B.-T., Heir, E., Fotland, T. Ø., Naterstad, K., & Kruse, H.
- Venue
- Microbial Drug Resistance
- Publisher
- SAGE Publications
- Published
- 2006-06
- Volume
- 12
- Issue
- 2
- Pages
- 83-90
- ISSN
- 1076-6294 (ISSN-L)
- 1931-8448
- OpenAlex
- W2003808881
- Cited by
- 362
- References
- 64
- FWCI
- 6.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.